These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7535157)

  • 1. Is non-invasive diagnosis possible in Down's syndrome?
    Ioan DM; Lăpădat R
    Rom J Endocrinol; 1993; 31(3-4):199-200. PubMed ID: 7535157
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved antenatal screening for Down's syndrome.
    Benn P
    Lancet; 2003 Mar; 361(9360):794-5. PubMed ID: 12642040
    [No Abstract]   [Full Text] [Related]  

  • 3. Prenatal screening for Down's syndrome.
    Gocze PM; Arany A; Freeman DA
    N Engl J Med; 1992 Dec; 327(27):1951; author reply 1952-3. PubMed ID: 1280772
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome.
    Ogueh O
    Br J Obstet Gynaecol; 1995 Apr; 102(4):349-50. PubMed ID: 7542022
    [No Abstract]   [Full Text] [Related]  

  • 6. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual analyte screening for fetal Down syndrome in pregnant women over 35 years of age.
    Cavalli P; Gnocchi E; Pennacchio A; Morrica B
    Prenat Diagn; 1998 Jun; 18(6):637-8. PubMed ID: 9664616
    [No Abstract]   [Full Text] [Related]  

  • 9. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
    Reynolds T; Ellis A; Jones R
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening for Down's syndrome.
    Campbell TL
    N Engl J Med; 1986 Jun; 314(23):1516. PubMed ID: 2422554
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal screening policies for Down's syndrome. Serum screening for Down's syndrome is better than age screening.
    Christiansen M; Larsen SO; Nørgaard-Pedersen B
    BMJ; 2002 Nov; 325(7371):1034; author reply 1034. PubMed ID: 12420332
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving methods of screening for Down's syndrome.
    White I; Papiha SS; Magnay D
    N Engl J Med; 1989 Feb; 320(6):401-2. PubMed ID: 2464139
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF
    Med J Aust; 1991 Jul; 155(2):67-8. PubMed ID: 1713290
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
    Spencer K
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):413-4. PubMed ID: 11471889
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal chromosome analysis today. Screening by maternal age or serum test?
    Salonen R
    Acta Obstet Gynecol Scand; 1993 Apr; 72(3):146-7. PubMed ID: 7682376
    [No Abstract]   [Full Text] [Related]  

  • 18. [Maternal serum AFP determination in the 2d trimester: a suitable screening method for detection of fetuses with Down's syndrome in young females?].
    Mühlhaus K; Bock J
    Z Geburtshilfe Perinatol; 1990; 194(2):70-4. PubMed ID: 1693025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal alpha-fetoprotein screening for Down's syndrome.
    Pueschel SM
    N Engl J Med; 1987 Aug; 317(6):376-8. PubMed ID: 2439910
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.